Psychosocial Risk Scale (PRS) for breast cancer in patients with breast disease: A prospective case-control study in Kuopio, Finland

Anticancer Research

Volumn 29, Issue 11, 2009, Pages 4765-4770

  Eskelinen, Matti ^a   Ollonen, Paula ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b State Office in Eastern Finland   (Finland)

Author keywords

Breast cancer; Breast disease; Psychosocial risk scale

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BREAST CANCER; BREAST DISEASE; CANCER GRADING; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; DEPRESSION; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PHYSICIAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SOCIAL PSYCHOLOGY;

BREAST DISEASES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHOLOGICAL TESTS; QUESTIONNAIRES; RISK FACTORS;

EID: 75149197311     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Key JA, Verkasalo PK and Banks E: Epidemiology of breast cancer. Lancet Oncol 2: 133-140, 2001.
2. Mitranen K and Hirvonen A: Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 544: 9-41,2003.
3. Männistö S, Pietinen P, Pyy M, Palmgren J, Eskelinen M and Uusitupa M: Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status. Int J Cancer 68: 8-13,1996.
4. Mitranen K, Kataja V, Eskelinen M, Kosma VM, Kang D, Benhamou S, Vainio H, Uusitupa M and Hirvonen A: Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk. Pharmacogenetics 12: 67-72,2002.
5. Eskelinen M, Norden T, Lindgren A, Wide L, Adami HO and Holmberg L: Preoperative serum levels of follicle-stimulating hormone (FSH) and prognosis in invasive breast cancer. EJSO 30: 495-500, 2004.
6. Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma V-M, Uusitupa M, Vainio H and Mitranen K: NAT2 slow acetylator genotype as an important modifier of breast cancer risk. Int J Cancer 114: 579-584, 2005.
7. Sillanpää P, Kataja V, Eskelinen M, Kosma V-M, Uusitupa M, Vainio H, Mitranen K and Hirvonen A: Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women. Pharmacogenetics 15: 749-752, 2005.
8. Chen CC, David AS, Nunnerley H, Michell M, Dawson JL, Berry H, Dobbs J and Fahy T: Adverse life events and breast cancer: case control study. BMJ 311: 1527-1530, 1995.
9. Roberts FD, Newcomb PA, Trentham-Dietz A and Storer BE: Self-reported stress and risk of breast cancer. Cancer 77: 1089-1093,1996.
10. McKenna MC, Zevon MA, Corn B and Rounds J: Psychosocial factors and the development of breast cancer: a meta-analysis. Health Psychol 18: 520-531, 1999.
11. Protheroe D, Turvey K, Horgan K, Benson E, Bowers D and House A: Stressful life events and difficulties and onset of breast cancer: case-control study. BMJ 319: 1027-1030, 1999.
12. Price MA, Tennant CC, Butow PN, Smith RC, Kennedy SJ, Kossoff MB and Dunn SM: The role of psychosocial factors in the development of breast carcinoma: Part II. Life event stressors, social support, defense style, and emotional control and their interactions. Cancer 91: 686-697, 2001.
13. Duijts SFA, Zeegers MPA and Vd Borne B: The association between stressful life events and breast cancer risk: a meta-analysis. Int J Cancer 107: 1023-1029, 2003.
14. Morris T, Greer S, Pettingale TW and Watson M: Patterns of expression of anger and their psychosocial correlates in women with breast cancer. J Psychosom Res 25: 111-117,1981.
15. Wirsching M, Stierlin H, Hoffman F, Weber G and Wirsching B: Psychological identification of breast cancer patients before biopsy. J Psychosom Res 26: 1-10, 1982.
16. Jansen MA and Muenz LR: A retrospective study of personality variables associated with fibrocystic disease and breast cancer. J Psychosom Res 28: 35-42, 1984.
17. Pettingale KW, Watson M and Greer S: The validity of emotional control as a trait in breast cancer patients. J Psychosoc Oncol 2: 21-30, 1984.
18. Grassi L and Capellari L: State and trait psychological characteristics of breast cancer patients. New Trends Exp Clin Psychiatry 4: 99-109,1988.
19. Fox CM, Harper AP, Hyner GC and LyIe RM: Loneliness, emotional repression, marital quality, and major life events in women who developed breast cancer. J Comm Health 19: 467-482, 1994.
20. O'Donnell MC, Fisher R, Irvine K, Rickard M and McConaghy N: Emotional suppression: can it predict cancer outcome in women with suspicious screening mammograms? Psychol Med 30: 1079-1088,2000.
21. Price MA, Tennant CC, Smith RC, Butow PN, Kennedy SJ, Kossoff MB and Dunn SM: The role of psychosocial factors in the development of breast carcinoma: Part I. The cancer-prone personality. Cancer 91: 679-685, 2001.
22. Ollonen P, Lehtonen J and Eskelinen M: Stressful and adverse life experiences in patients with breast symptoms; a prospective case-control study in Kuopio, Finland. Anticancer Res 25: 531-536,2005.
23. Ollonen P, Lehtonen J and Eskelinen M: Anxiety, depression and history of psychiatric symptoms in patients with breast disease; a prospective case-control study in Kuopio, Finland. Anticancer Res 25: 2527-2534, 2005.
24. Ollonen P, Lehtonen J and Eskelinen M: Coping and defending as risk factors for breast cancer in patients with breast disease; a prospective case-control study in Kuopio, Finland. Anticancer Res 25: 4623-4630, 2005.
25. Ollonen P and Eskelinen M: Idealization as a risk factor for breast cancer in patients with breast disease a prospective case-control study in Kuopio, Finland. Anticancer Res 27: 1625-1630,2007.
26. Wirsching M, Hoffman F, Stierlin H, Weber G and Wirsching B: Prebioptic psychological characteristics of breast cancer patients. Psychother Psychosom 43: 69-76, 1985.
27. Boyle P: SEARCH programme of the International Agency for Research on Cancer. Eur J Cancer 26: 547-549, 1990.
28. Eskelinen M, Collan Y, Leivonen M, Hertsi M, Valkamo E, Puittinen J and Karosto R: Detection of breast cancer. A study of women with breast cancer symptoms. Theor Surg 3: 111-117, 1988.
29. Mitranen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Vainio H, Uusitupa M and Hirvonen A: Steroid metabolism gene CYP17 polymorphism and the development of breast cancer. Cancer Epidemiol Biomarkers Prev 9: 1343-1348, 2000.
30. Mitranen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Vainio H, Uusitupa M and Hirvonen A: Glutathione-s-transferase M1, M3, P1 and T1 genetic polymorphism and susceptibility to breast cancer. Cancer Epidemiol Biomarkers Prev 10:229-236,2001.
31. Haan N:.Coping and Defending Process of Self-environment Organization. New York, Academic Press: 1977.
32. Beck AT, Ward CH, Mendelson M, Mock J and Erbaugh J: An inventory for measuring depression. Arch Gen Psych 4: 53-61, 1961.
33. Beck AT, Steer RA and Garbin MG: Psychometric properties of the Beck depression inventory: Twenty-five years of evaluation. Clin Psychol Rev 8: 77-100, 1988.
34. Spielberger CD: Manual for the State-Trait Anxiety Inventory STAI (Form Y) (Self-evaluation questionnaire). Palo Alto, California, Consulting Psychologists Press: 1983.
35. Montgomery SA and Åsberg M: A new depression scale designed to be sensitive to change. Br J Psych 134: 322-389, 1879.
36. Finnish Cancer Registry. Cancer Statistics for Finland, March 2, 2004. http://www.cancerregistry.fi/
37. Temoshok L: Personality, coping style, emotion and cancer: towards an integrative model. Cancer Surv 6: 545-567, 1987.
38. McGee R: Does stress cause cancer? There's no good evidence of a relation between stressful events and cancer. BMJ 319: 1015-1016,1999.